Group A Streptococcal Infections in Children

Area of Science:

• Pediatric Infectious Diseases
• Clinical Microbiology
• Epidemiology of Bacterial Infections

Background:

• Invasive group A streptococcal disease (iGAS) is increasingly recognized in children, associated with severe outcomes including prolonged hospitalization, mortality, and long-term morbidity.
• The rising incidence of iGAS globally necessitates a renewed focus on effective early diagnosis, management, and prevention strategies.

Purpose of the Study:

• To review the diverse clinical presentations of iGAS in pediatric patients.
• To analyze the management strategies and outcomes for children diagnosed with iGAS infections.

Main Methods:

• Retrospective review of medical data for 57 children with confirmed iGAS from sterile site cultures over an 8-year period.
• Analysis of clinical presentations, diagnostic methods, antibiotic treatments (initial and optimized), length of stay, intensive care unit admission, and patient outcomes, including mortality and readmissions.

Main Results:

• The incidence of iGAS was 6-7 cases annually, with a mean hospital stay of 11 days; 21.1% required intensive care.
• Fever was the most common symptom, and pneumonia with or without empyema was the most frequent diagnosis.
• Antibiotic management varied, with ceftriaxone commonly used initially, and 50% later optimized to IV benzylpenicillin; 7% of patients died.

Conclusions:

• The study underscores the varied clinical spectrum of iGAS in children.
• Early and accurate diagnosis, coupled with prompt administration of appropriate antibiotics, is vital for improving patient outcomes and reducing mortality in pediatric iGAS cases.